← Dashboard
Pipeline: Profile → Scout → Research → Draft → Applied

Sofinnova Biotech Acceleration Fund

MODERATE Tx General
Strategy Notes
The fund targets early-stage European biotechs with management support and network access, aligning with the venture's EU focus and pre-seed stage. However, it is a VC vehicle, not a grant, and the venture's non-dilutive preference may reduce fit.
Key Materials
—
Your Notes
Status & Deadline
Status
INELIGIBLE
Deadline
—
Cycle
rolling
Amount
€165M
Type
vc
URL
Apply
Update Status
Log Application
AI Pipeline
Research Programme Generate Draft
Status History
2026-07-28 OPEN → INELIGIBLE · The Sofinnova Biotech Acceleration Fund is a venture capital vehicle, not a grant or fellowship. It requires a company/startup structure and is dilutive equity-based. The applicant is an independent researcher with no incorporated entity, and the fund targets early-stage European biotechs with management support, not individual researchers.